About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Effect of PF-00734200 in Subjects With Type 2 Diabetes

NCT00618007·79 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Pfizer

Age

18–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Men or women between 18-80 years of age with poorly controlled Type 2 diabetes

You may not be if

Type 1 or secondary forms of diabetes Currently using insulin

The record

StatusCompleted

PhasePhase 2

Taking part289

StartedFeb 2008

UpdatedJun 27, 2011

Conditions

Diabetes Mellitus, Type 2

Where79

Pfizer Investigational Site
Birmingham, Alabama, United States
Pfizer Investigational Site
Chandler, Arizona, United States
Pfizer Investigational Site
Litchfield Park, Arizona, United States

Clareo Health | Effect of PF-00734200 in Subjects With Type 2 Diabetes